Thymic development of human natural killer T cells: recent advances and implications for immunotherapy

被引：0
|
作者：
Pellicci, Daniel G. [1 ,2 ,3 ]
Tavakolinia, Naeimeh [1 ,2 ]
Perriman, Louis [1 ,4 ,5 ]
Berzins, Stuart P. [2 ,5 ]
Menne, Christopher [1 ]
机构：
[1] Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
[4] Fiona Elsey Canc Res Inst, Ballarat, Vic, Australia
[5] Federat Univ Australia, Ballarat, Vic, Australia
来源：
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
基金：
澳大利亚国家健康与医学研究理事会;
关键词：
unconventional T cells; unconventional T cell development; cytokines; cytotoxic granules; immunotherapy; INVARIANT NKT CELLS; TRANSCRIPTION FACTOR PLZF; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; HUMAN INKT; LINEAGE; SUBSETS; CD4(+); CD1D; EXPRESSION;
D O I：
10.3389/fimmu.2024.1441634
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Invariant natural killer T (iNKT) cells are a subset of lipid-reactive, unconventional T cells that have anti-tumor properties that make them a promising target for cancer immunotherapy. Recent studies have deciphered the developmental pathway of human MAIT and V gamma 9V delta 2 gamma delta-T cells as well as murine iNKT cells, yet our understanding of human NKT cell development is limited. Here, we provide an update in our understanding of how NKT cells develop in the human body and how knowledge regarding their development could enhance human treatments by targeting these cells.
引用
收藏
页数：10
相关论文
共 50 条
  • [1] Human invariant natural killer T cells: implications for immunotherapy
    Tsuyoshi Takahashi
    Mineo Kurokawa
    International Journal of Hematology, 2009, 90 : 137 - 142
  • [2] Human invariant natural killer T cells: implications for immunotherapy
    Takahashi, Tsuyoshi
    Kurokawa, Mineo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 90 (02) : 137 - 142
  • [3] Early stages in the development of human T, natural killer and thymic dendritic cells
    Spits, H
    Blom, B
    Jaleco, AC
    Weijer, K
    Verschuren, MCM
    van Dongen, JJM
    Heemskerk, MHM
    Res, PCM
    IMMUNOLOGICAL REVIEWS, 1998, 165 : 75 - 86
  • [4] RECENT ADVANCES IN HUMAN NATURAL-KILLER-CELLS
    MORETTA, L
    CICCONE, E
    BIASSONI, R
    POGGI, A
    MINGARI, MC
    MORETTA, A
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1992, 99 (2-4) : 230 - 233
  • [5] Genetic modification of human Natural Killer cells: Implications for cancer immunotherapy
    Naylor, CS
    Gilham, DE
    Hawkins, RE
    BRITISH JOURNAL OF CANCER, 2001, 85 : 97 - 97
  • [6] Immunotherapy with ligands of natural killer T cells
    Wilson, MT
    Singh, AK
    Van Kaer, L
    TRENDS IN MOLECULAR MEDICINE, 2002, 8 (05) : 225 - 231
  • [7] Natural Killer T Cells in Cancer immunotherapy
    Nair, Shiny
    Dhodapkar, Madhav V.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [8] DEVELOPMENT OF HUMAN T-CELLS AND NATURAL-KILLER-CELLS
    SPITS, H
    LANIER, LL
    PHILLIPS, JH
    BLOOD, 1995, 85 (10) : 2654 - 2670
  • [9] Invariant natural killer T cells and immunotherapy of cancer
    Molling, Johan W.
    Moreno, Maria
    van der Vliet, Hans J. J.
    van den Eertwegh, Alfons J. M.
    Scheper, Rik J.
    von Blomberg, B. Mary E.
    Bontkes, Hetty J.
    CLINICAL IMMUNOLOGY, 2008, 129 (02) : 182 - 194
  • [10] Application of natural killer T cells in antitumor immunotherapy
    Hong, Changwan
    Park, Se-Ho
    CRITICAL REVIEWS IN IMMUNOLOGY, 2007, 27 (06) : 511 - 525
12345